Previous Close | 0.1353 |
Open | 0.2190 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.2190 - 0.2190 |
52 Week Range | 0.0505 - 2.0900 |
Volume | |
Avg. Volume | 636 |
Market Cap | 737,892 |
Beta (5Y Monthly) | 0.09 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -7.8000 |
Earnings Date | May 27, 2024 - May 31, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.00 |
LOS ANGELES, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) reported its financial results for its third quarter of fiscal 2023, the period ended September 30, 2023, on www.sedar.com. Financial Highlights for Q3 2023 Q3 revenue was $19.1 million, down 13.4% from $22.0 million in Q3 2022.Income from operations decreased $2.9 million from $0.6 million in Q3 2022 to a loss of $2.3 million in Q3 2023. The decrease is primarily att
LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) reported its financial results for its second quarter of fiscal 2023, the period ended June 30, 2023, on www.sedar.com. Financial Highlights for Q2 2023 Q2 revenue was $22.1 million, up 1.5% from $21.8 million in Q2 2022.Income from operations decreased $2.4 million from $0.5 million in Q2 2022 to a loss of $1.9 million in Q2 2023. The decrease is primarily attributed
LOS ANGELES, July 28, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) a leading innovator in natural health products, is catapulting into the California cannabis market with its line of Power to Sleep, Get Lit, and Balance tinctures through a licensing and supply agreement with The Hive Laboratory, LLC ("The Hive”) as announced previously. Available now for wholesale, these revolutionary products promise to redefine the cannabis experie